Pegylated interferon &alpha;-2b plus ribavirin for older patients with chronic hepatitis C

doi:10.3748/wjg.v16.i35.4400

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4198)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

300

HTML

3413

Figures (1-2)

244

Tables (1-5)

241

Sum=4198

Sep 21, 2010 (publication date) through Dec 29, 2024

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Sep 21, 2010; 16(35): 4400-4409
Published online Sep 21, 2010. doi: 10.3748/wjg.v16.i35.4400

Full Size Figure Download Figure

Figure 2 Virological response to the combination treatment by age of patients with genotype 1 (A) and genotype 2 (B). SVR: Sustained virological response; CI: Confidence interval.

Citation: Kainuma M, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Azuma K, Shimono J, Shimoda S, Hayashi J, Group TKULDS. Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C. World J Gastroenterol 2010; 16(35): 4400-4409
URL: https://www.wjgnet.com/1007-9327/full/v16/i35/4400.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i35.4400